Fermenta Biotech has scheduled a one-to-one physical meeting in Mumbai, where company officials will engage with investors.

This interaction will focus on information from publicly available Press Releases and Investor Presentations.

The company explicitly stated that no unpublished price sensitive information will be shared during these meetings, ensuring transparent communication and fair disclosure for all stakeholders.

This activity represents routine investor outreach, allowing direct engagement without disclosing new material developments.